BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22586083)

  • 21. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.
    Wang L; Shi ZM; Jiang CF; Liu X; Chen QD; Qian X; Li DM; Ge X; Wang XF; Liu LZ; You YP; Liu N; Jiang BH
    Oncotarget; 2014 Jul; 5(14):5416-27. PubMed ID: 24980823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
    Albanese C; Alzani R; Amboldi N; Degrassi A; Festuccia C; Fiorentini F; Gravina G; Mercurio C; Pastori W; Brasca M; Pesenti E; Galvani A; Ciomei M
    Br J Pharmacol; 2013 May; 169(1):156-66. PubMed ID: 23347136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.
    Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
    BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
    Momota H; Nerio E; Holland EC
    Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
    Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
    Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway.
    Chen L; Han L; Shi Z; Zhang K; Liu Y; Zheng Y; Jiang T; Pu P; Jiang C; Kang C
    Mol Med Rep; 2012 Feb; 5(2):575-9. PubMed ID: 22086271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells.
    Chu PM; Chen LH; Chen MT; Ma HI; Su TL; Hsieh PC; Chien CS; Jiang BH; Chen YC; Lin YH; Shih YH; Tu PH; Chiou SH
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):621-33. PubMed ID: 21947203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
    Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G
    Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells.
    Zhang C; Cai Z; Liang Q; Wang Q; Lu Y; Hu L; Hu G
    Cell Mol Neurobiol; 2017 Apr; 37(3):555-562. PubMed ID: 27473470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
    Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
    Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.
    Liu X; Wang L; Chen J; Ling Q; Wang H; Li S; Li L; Yang S; Xia M; Jing L
    Mol Med Rep; 2015 Feb; 11(2):1516-22. PubMed ID: 25351348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells.
    Zhang H; Kong X; Kang J; Su J; Li Y; Zhong J; Sun L
    Toxicol Sci; 2009 Aug; 110(2):376-88. PubMed ID: 19451193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferase.
    Fukai J; Koizumi F; Nakao N
    PLoS One; 2014; 9(8):e104538. PubMed ID: 25111384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
    Oliveira KA; Dal-Cim TA; Lopes FG; Nedel CB; Tasca CI
    Purinergic Signal; 2017 Sep; 13(3):305-318. PubMed ID: 28536931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gartanin induces cell cycle arrest and autophagy and suppresses migration involving PI3K/Akt/mTOR and MAPK signalling pathway in human glioma cells.
    Luo M; Liu Q; He M; Yu Z; Pi R; Li M; Yang X; Wang S; Liu A
    J Cell Mol Med; 2017 Jan; 21(1):46-57. PubMed ID: 27491646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
    Shi Z; Chen Q; Li C; Wang L; Qian X; Jiang C; Liu X; Wang X; Li H; Kang C; Jiang T; Liu LZ; You Y; Liu N; Jiang BH
    Neuro Oncol; 2014 Oct; 16(10):1341-53. PubMed ID: 24861879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.